TD Cowen analyst Craig Hutchison maintained a Buy rating on NexGen Energy (NXE – Research Report) today and set a price target of ...

Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...

Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports.

The rating changes comes after Wednesday’s release of “in-line and mixed” fourth-quarter 2024 financial results, which saw it ...

Microsoft has walked away from some of its commitments with cloud computing provider CoreWeave in a significant blow to a company seeking to launch a blockbuster $35bn initial public offering next ...

Investment bank TD Cowen noted that President Donald Trump did not mention cryptocurrency in his Congress speech.

Economic forecasts have been weakening. While some see slower growth, several commentators see the chance of an outright ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

TD Cowen analyst Oliver Chen maintained a Hold rating on Nordstrom (JWN – Research Report) today and set a price target of $25.00. The ...

Calumet downgraded at TD Cowen, saying the market has more fully accounted for near-term risks both for the Montana Renewable ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

Merck’s stock has fallen 7.27% year-to-date, raising investor concerns. Despite a 1.84% gain on Friday, the stock remains ...